These Biomaterials Could Help to Make Stem Cell Therapies a Reality
British researchers have developed biomaterials that better recreate the conditions required for stem cells to…
British researchers have developed biomaterials that better recreate the conditions required for stem cells to…
Takeda has offered to acquire TiGenix subject to the upcoming European approval of its lead…
This week, we are in Prague to visit Bioinova. This biotech develops cell therapies for a…
Kiadis Pharma starts Phase III trials with ATIR101, a therapy that could make half-matched donors…
Alzheimer's disease is rapidly increasing in prevalence but we have no effective treatment. But, Finnish…
The 'butterfly child' who lost 80% of his skin has been successfully treated. The boy…
In our first part of the interview with Dr David Hallett, Executive Vice President at…
British researchers have created a new type of stem cell in mice. It has even greater…
Thomas Bold, CEO of RenovaCare, shares the story of how his team developed a futuristic…
In an exclusive interview with Dr David Hallett, we discover why iPS cells are the perfect…
When the Japanese researcher Shinya Yamanaka managed to reprogram adult cells into an embryonic-like state…
Arthur Lahr, CEO of Kiadis Pharma, explains the promising cell therapy the company is developing…